<code id='93118E245F'></code><style id='93118E245F'></style>
    • <acronym id='93118E245F'></acronym>
      <center id='93118E245F'><center id='93118E245F'><tfoot id='93118E245F'></tfoot></center><abbr id='93118E245F'><dir id='93118E245F'><tfoot id='93118E245F'></tfoot><noframes id='93118E245F'>

    • <optgroup id='93118E245F'><strike id='93118E245F'><sup id='93118E245F'></sup></strike><code id='93118E245F'></code></optgroup>
        1. <b id='93118E245F'><label id='93118E245F'><select id='93118E245F'><dt id='93118E245F'><span id='93118E245F'></span></dt></select></label></b><u id='93118E245F'></u>
          <i id='93118E245F'><strike id='93118E245F'><tt id='93118E245F'><pre id='93118E245F'></pre></tt></strike></i>

          leisure time

          leisure time

          author:Wikipedia    Page View:337
          Richard Burr
          North Carolina Senator Richard Burr received strong support from the biotech sector. Gerry Broome/AP

          WASHINGTON — A veteran senator and champion of the biotech sector beat back an unusually strong challenge Tuesday night — thanks in large part to loyal support from the industry.

          North Carolina Senator Richard Burr, a Republican who has long protected the bioscience companies that drive his state’s economy, overcame a surprisingly robust challenge from Democratic candidate Deborah K. Ross.

          advertisement

          Burr, now finishing his second term in the Senate, serves on committees with oversight of both the Food and Drug Administration and Medicare and Medicaid. He is also chairman of the Select Committee on Intelligence.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          Hollywood unions extend contract negotiations for actors
          Hollywood unions extend contract negotiations for actors

          1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

          read more
          Orchard's therapy for neuron disease in children wins FDA approval
          Orchard's therapy for neuron disease in children wins FDA approval

          AdobeTheFoodandDrugAdministrationonMondayapprovedagenetherapyformetachromaticleukodystrophy,adevasta

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Leading voice in opioid treatment defends methadone clinic system

          MarkParrino:"Idon’tthinkthedominantinterestisjustgivinglotsmoretake-homestopatients.There’smoretotre